Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

7.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.8K
Tonsillitis II: Management01:26

Tonsillitis II: Management

428
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
428
Impression Management Techniques I: Managing Appearances01:29

Impression Management Techniques I: Managing Appearances

216
Appearance is a multidimensional aspect of self-presentation that encompasses observable attributes such as clothing, grooming, speech, and nonverbal behavior. These elements are often strategically managed to align with socially constructed expectations in different settings. For instance, individuals tailor their appearance during job interviews, social gatherings, or athletic events to meet the perceived norms of those environments.Contextual Adaptation and Social SignalsThe research...
216
Managing Impressions01:19

Managing Impressions

169
Impression management encompasses individuals' deliberate efforts to shape how others perceive them during social interactions. This behavior is often employed to conform to social norms, secure approval, or pursue specific goals. While it involves selective self-presentation, it is not necessarily deceptive; individuals frequently present authentic aspects of themselves that align with situational demands.Common strategies include:Ingratiation: where individuals use flattery or agreeableness...
169
Management of Insomnia01:19

Management of Insomnia

630
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
630

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Centrilobular zonal necrosis is a unique subtype of autoimmune hepatitis: A cohort study.

Medicine·2022
Same author

The efficacy and safety of glecaprevir plus pibrentasvir in 141 patients with severe renal impairment: a prospective, multicenter study.

Alimentary pharmacology & therapeutics·2019
Same author

Mucinous carcinoma of the gallbladder with signet ring cells.

Radiology case reports·2018
Same author

Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C genotype 1b.

World journal of gastroenterology·2017
Same author

Daclatasvir and asunaprevir for genotype 1b chronic hepatitis C patients with chronic kidney disease.

Hepatology research : the official journal of the Japan Society of Hepatology·2017
Same author

Autoimmune hepatitis: current challenges and future prospects.

Clinical and experimental gastroenterology·2017

Related Experiment Video

Updated: Jan 30, 2026

Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH
07:13

Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH

Published on: April 20, 2021

4.6K

[Progress in the Management of NAFLD/NASH].

Yoshio Aizawa

    Rinsho Byori. the Japanese Journal of Clinical Pathology
    |January 30, 2019
    PubMed
    Summary

    Non-alcoholic fatty liver disease (NAFLD) is a common liver condition linked to metabolic syndrome. Lifestyle changes and new drugs like obeticholic acid show promise for managing non-alcoholic steatohepatitis (NASH).

    Area of Science:

    • Hepatology
    • Gastroenterology
    • Metabolic Diseases

    Background:

    • Non-alcoholic fatty liver disease (NAFLD) encompasses simple steatosis (NAFL) to non-alcoholic steatohepatitis (NASH) and cirrhosis.
    • NAFLD is a hepatic manifestation of metabolic syndrome, strongly associated with insulin resistance.
    • Key factors in NAFLD/NASH development include adiponectin, TNF-alpha, gut microbiota, and genetic susceptibility (PNPLA3, MTHFR).

    Purpose of the Study:

    • To review recent advances in the epidemiology, etiology, diagnosis, and treatment of NAFLD/NASH.
    • To highlight the roles of metabolic factors, genetics, and gut microbiota in NAFLD.
    • To discuss current and emerging therapeutic strategies for NAFLD and NASH.

    Main Methods:

    • Literature review of recent scientific advancements in NAFLD/NASH.

    More Related Videos

    Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
    04:14

    Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

    Published on: April 16, 2019

    12.7K
    Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
    08:41

    Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

    Published on: March 24, 2023

    1.8K

    Related Experiment Videos

    Last Updated: Jan 30, 2026

    Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH
    07:13

    Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH

    Published on: April 20, 2021

    4.6K
    Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
    04:14

    Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

    Published on: April 16, 2019

    12.7K
    Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
    08:41

    Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

    Published on: March 24, 2023

    1.8K
  • Analysis of diagnostic criteria including liver biopsy, Matteoni's classification, and Brunt's staging.
  • Evaluation of prevention strategies and pharmacological treatments.

    • Main Results:

    • NAFLD diagnosis relies on liver biopsy, with staging based on established classifications.
    • Lifestyle modifications (diet, exercise) are crucial for prevention and treatment.
    • Current pharmacotherapies (vitamin E, pioglitazone, liraglutide) have limitations, but obeticholic acid shows promise for NASH.

    Conclusions:

    • NAFLD is a complex condition with multifactorial etiology.
    • Effective management requires lifestyle changes and potentially novel pharmacotherapies.
    • Obeticholic acid represents a promising therapeutic option for NASH.